SA Transcripts • Oct. 23, 2014
From other sites
There are no Focus articles on NVZMF.
Dec. 11, 2013, 10:29 AM
- Monsanto (MON) is teaming up with a Danish biotech Novozymes (NVZMF, NVZMY) to develop microscopic organisms that help plants grow and resist pests, a move that could enable it to circumvent some concerns over its genetically modified seeds.
- MON will pay $300M as part of the deal, in which the companies plan to combine their efforts to cultivate beneficial bacteria; they will split the cost of development equally and each get 50% of the profits from sales.
- The idea of using microbes for plants hasn't caught on yet in part because many of the largest farmers are used to growing crops with synthetic fertilizer, scientists say.
There are no StockTalks on this stock yet.
NVZMF vs. ETF Alternatives
Novozymes is the biotech-based world leader in enzymes and microorganisms. With more than 100 types of enzymes and microorganisms and not less than 700 different products Novozymes has the largest product portfolio in the world. <br />In more than 40 different industries and 130 countries, our... More
Other News & PR